FindTrial
Sign In

Predicting Cervical Lymph Node Metastasis and Its Biological Mechanisms in Pediatric Thyroid Cancer Based on Ultrasound Radiomics

Predicting Cervical Lymph Node Metastasis and Its Biological Mechanisms in Pediatric Thyroid Cancer Based on Ultrasound Radiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118879
Enrollment
Unknown
Registered
2026-02-12
Start date
2026-02-12
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Thyroid cancer observation group:None

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age <= 18 years old; 2. Postoperative pathological diagnosis is thyroid cancer; 3. Complete preoperative ultrasound imaging data and surgical resection tissue samples are available; 4. There are at least 3 years of follow-up data after the surgery, including clinical information such as metastasis and recurrence; 5. Tumor tissue samples that meet quality inspection standards are obtained.

Exclusion criteria

Exclusion criteria: 1. Merge with other malignant tumors; 2. Received anti-tumor treatments such as radiotherapy and chemotherapy before the surgery; 3. The quality of the ultrasound images is poor, making feature extraction impossible; 4. The tissue samples were improperly preserved, preventing sequencing analysis.

Design outcomes

Primary

MeasureTime frame
Ultrasound imaging omics;—

Countries

China

Contacts

Public ContactChengyu Fang

Zhejiang Cancer Hospital

fangcy2997@zjcc.org.cn+86 579 8712 5755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026